Inovio price prediction


Inovio Pharma stock price prediction is an act of determining the future value of Inovio Pharma shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Inovio Pharma’s future price could yield a significant profit.

The 4 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 2.50, with a high estimate of 8.00 and a low estimate of 1.00. The median estimate represents a +29.87% increase from the last price of 1.93.


What is target price for Inovio?

Stock Price Target INOHigh$8.00Median$2.50Low$1.00Average$3.50Current Price$1.87

Is INO a Buy Sell or Hold?

The Inovio Pharmaceuticals stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock.

Will INO stock go back up?

Based on our forecasts, a long-term increase is expected, the “INO” stock price prognosis for 2027-06-16 is 3.608 USD. With a 5-year investment, the revenue is expected to be around +92.45%. Your current $100 investment may be up to $192.45 in 2027.

Who is invested in Inovio?

Top 10 Owners of Inovio Pharmaceuticals IncStockholderStakeShares bought / soldGeode Capital Management LLC1.66%+351,457Northern Trust Investments, Inc.(…0.89%-50,442Susquehanna Financial Group LLLP0.87%+207,347Goldman Sachs Asset Management LP0.69%-158,1516 more rows

Can INO defeat Sakura?

6 Could Defeat: Ino Yamanaka Being a member of Team 10, Ino is well-versed in dealing with enemies who are stronger than her through strategizing alone. However, Sakura is not only far stronger than Ino but also knows her way of fighting extremely well. Anything Ino would throw her way would be useless in their fight.

Is inovio publicly traded?

Inovio stock traded below 10 per share in December. The company has a pipeline of drugs in development for cancer and infectious diseases.

Should I hold Inovio stock?

The consensus among Wall Street analysts is that investors should “buy” Annovis Bio stock.

Whats happening with Inovio?

Inovio Pharmaceuticals Inc will discontinue a late-stage study of its COVID-19 vaccine, the company said on Tuesday, and appointed its operating chief as the new chief executive, sending the company’s shares down nearly 20% after the bell.

Why is INO down?

[Updated: Dec 17, 2021] INO Stock Decline This can be attributed to the spread of the new Covid-19 variant – Omicron. Inovio is developing INO-4800 – its Covid-19 vaccine candidate, which is now in late stage clinical trials and it is still several months before it can hit the market, subject to regulatory approval.

What happened to Inovio Covid vaccine?

Shares of Inovio Pharmaceuticals are down more than 22% in premarket trading after the company announced a leadership change at the helm and the discontinuation of a Phase III COVID-19 vaccine study.

Does inovio have a Covid vaccine?

INOVIO scientists are coronavirus experts. INOVIO was the first to advance its DNA vaccine INO-4700 against MERS CoV, a related coronavirus, into evaluation in humans.

Who owns VXRT?

Armistice Capital, Llc Care Capital III LLC Care Capital Investments III L.P.

Should I buy or sell Inovio Pharmaceuticals stock right now?

5 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Inovio Pharmaceuticals in the last twelve months. There are currently 5 ho…

What is Inovio Pharmaceuticals’ stock price forecast for 2022?

5 Wall Street research analysts have issued 12-month price objectives for Inovio Pharmaceuticals’ shares. Their forecasts range from $3.00 to $35.0…

How has Inovio Pharmaceuticals’ stock price performed in 2022?

Inovio Pharmaceuticals’ stock was trading at $4.99 on January 1st, 2022. Since then, INO shares have decreased by 69.7% and is now trading at $1.51…

Are investors shorting Inovio Pharmaceuticals?

Inovio Pharmaceuticals saw a drop in short interest in the month of May. As of May 31st, there was short interest totaling 34,410,000 shares, a dro…

When is Inovio Pharmaceuticals’ next earnings date?

Inovio Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022. View our earnings forecast for…

How were Inovio Pharmaceuticals’ earnings last quarter?

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) posted its earnings results on Tuesday, May, 10th. The biopharmaceutical company reported ($0.36) earning…

When did Inovio Pharmaceuticals’ stock split? How did Inovio Pharmaceuticals’ stock split work?

Inovio Pharmaceuticals shares reverse split on Friday, June 6th 2014. The 1-4 reverse split was announced on Friday, May 23rd 2014. The number of s…

Who are Inovio Pharmaceuticals’ key executives?

Inovio Pharmaceuticals’ management team includes the following people: Dr. J. Joseph Kim Ph.D. , CEO, Pres & Director (Age 53, Pay $1.31M) Mr. P…

What is J. Joseph Kim’s approval rating as Inovio Pharmaceuticals’ CEO?

12 employees have rated Inovio Pharmaceuticals CEO J. Joseph Kim on . J. Joseph Kim has an approval rating of 82% among Inovio Pharm…

“Should I invest in
Inovio Pharmaceuticals stock?” “Should I trade “INO” stock today?”

According to our live Forecast System,
Inovio Pharmaceuticals Inc stock is
a very good long-term (1-year)…

What is
the Inovio Pharmaceuticals stock price / share price today?

The Inovio Pharmaceuticals stock price is
USD today.

Will Inovio Pharmaceuticals stock price grow / rise / go

Yes. The INO stock price can go up
3.230 USD to
4.441 USD in…

Is it profitable to
invest in Inovio Pharmaceuticals stock?

Yes. The long-term earning potential is
+ 37.48 %
in one year.

Will INO stock price fall / drop?

No. See above .

will Inovio Pharmaceuticals stock price be worth in five years

The INO (“INO” )
future stock price will be
9.137 USD .

Will INO stock price crash?

According to our analysis, this will not happen.

Will Inovio Pharmaceuticals stock price
hit 10 USD price in a year?

Not within a year.
See above .

Will Inovio Pharmaceuticals stock price
hit 20 USD price in a year?

Not within a year.
See above .

How much does Inovio make?

How much money does Inovio Pharmaceuticals make? Inovio Pharmaceuticals has a market capitalization of $2.02 billion and generates $7.41 million in revenue each year . The biopharmaceutical company earns $-166,410,000.00 in net income (profit) each year or ($0.82) on an earnings per share basis.

When did the 1-4 reverse split happen?

The 1-4 reverse split was announced on Friday, May 23rd 2014. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 5th 2014. An investor that had 100 shares of Inovio Pharmaceuticals stock prior to the reverse split would have 25 shares after the split.

Analyst price target for INO

Based on 3 analyst s offering 12 month price targets for Inovio Pharmaceuticals Inc.

INO earnings per share forecast

What is INO ‘s earnings per share in the next 3 years based on estimates from 6 analyst s?

INO revenue forecast

What is INO ‘s revenue in the next 3 years based on estimates from 4 analyst s?

INO revenue growth forecast

How is INO forecast to perform vs Biotechnology companies and vs the US market?

Historical and forecast chart of Inovio Pharmaceuticals stock

The chart below shows the historical price of Inovio Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast.

Inovio Pharmaceuticals Daily Price Targets

Forecast target price for 03-01-2022: $ 3.41. Positive dynamics for Inovio Pharmaceuticals shares will prevail with possible volatility of 5.381%.

Inovio Pharmaceuticals forecast for this year

An downtrend is forecast for this month with an optimal target price of $ 3.16602. Pessimistic: $3.08. Optimistic: $3.38

Inovio Pharmaceuticals information and performance

Inovio Pharmaceuticals, Inc. a biotechnology company specializing in the discovery, development and commercialization of DNA drugs to treat, cure and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases.

Inovio Pharmaceuticals (NASDAQ:INO) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst’s rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).

Analyst Price Target Consensus

Sign-up to receive the latest news and ratings for INO and its competitors with MarketBeat’s FREE daily newsletter.

Analyst Ratings By Month

The chart below shows how a company’s ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

Average Share Price and Price Target by Month

The chart below shows how a company’s share price and consensus price target have changed over time. The dark blue line represents the company’s actual price. The lighter blue line represents the stock’s consensus price target.

Inovio Pharmaceuticals (NASDAQ:INO) Analyst Ratings Frequently Asked Questions

According to the issued ratings of 6 analysts in the last year, the consensus rating for Inovio Pharmaceuticals stock is Hold based on the current 5 hold ratings and 1 buy rating for INO. The average twelve-month price target for Inovio Pharmaceuticals is $12.60 with a high price target of $35.00 and a low price target of $6.00.

INO : Inovio Pharmaceuticals stock forecast by Wall Street Analysts

The average Inovio Pharmaceuticals stock forecast from last 6 month is $7.0, and this show a -12.5% decrease in average from the prior price target of the each prediction. Also, this average forecast of $7.0 represents a -36.36% decrease from the past average forecast of $11.0, 6 months ago from 2 wall street analysts.

Frequently Asked Questions about Inovio Pharmaceuticals stock forecast

From Inovio Pharmaceuticals stock forecast , Inovio Pharmaceuticals (INO) stock cannot be a good investment choice. According to AI Pickup, the Inovio Pharmaceuticals stock price forecast for 2022 Mar. is $3.08052179823623


Leave a Comment